# Feasibility of Blood Glucose Control With the Space TGC System in Postoperative Cardiac Surgery Patients in the ICU

> **NCT01233271** · NA · COMPLETED · sponsor: **B. Braun Melsungen AG** · enrollment: 10 (estimated)

## Conditions studied

- Critical Illness

## Interventions

- **DEVICE:** Space TGC

## Key facts

- **NCT ID:** NCT01233271
- **Lead sponsor:** B. Braun Melsungen AG
- **Sponsor class:** INDUSTRY
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2010-11
- **Primary completion:** 2011-04
- **Final completion:** 2011-04
- **Target enrollment:** 10 (ESTIMATED)
- **Last updated:** 2011-06-09


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01233271

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01233271, "Feasibility of Blood Glucose Control With the Space TGC System in Postoperative Cardiac Surgery Patients in the ICU". Retrieved via AI Analytics 2026-05-31 from https://api.ai-analytics.org/clinical/NCT01233271. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*